Prices delayed by at least 15 minutes | Print
BioGaia AB ser. B (BIOG B)
This share can be held in a Dealing accountISALifetime ISAJISASIPP
Company profile
BioGaia AB is a healthcare company engaged in developing, marketing, and selling probiotic products. The company has three operating segments; Paediatrics segment includes drops, gut health tablets, oral rehydration solution (ORS) and cultures to be used as ingredients in licensee products such as infant formula, as well as royalty revenue for pediatric products, Adult Health segment includes gut health tablets, oral health lozenges and cultures as an ingredient in a licensee's dairy products, and Other segment include royalties in respect of development projects, revenue from packaging solutions in the subsidiary CapAble, etc. Geographically, it operates in three regions; Asia Pacific, Europe, the Middle East, Africa, and the Americas.
Address
Kungsbroplan 3A
P.O.Box 3242
Stockholm
SWE
SE 103 64
Telephone
+46 855529304
Forecast key dates
| Name | Key Date |
|---|---|
| BioGaia AB First Quarter Earnings Conference Call for 2025 | 2025-05-07T08:00:00 |
| BioGaia AB First Quarter Earnings Results for 2025 | 2025-05-07T00:00:00 |
| BioGaia AB Annual General Meeting for 2025 | 2025-05-07T00:00:00 |
| BioGaia AB Annual Report for 2024 | 2025-03-26T00:00:00 |
| BioGaia AB Fourth Quarter Earnings Conference Call for 2024 | 2025-02-07T09:30:00 |
| BioGaia AB Fourth Quarter Earnings Results for 2024 | 2025-02-07T00:00:00 |
| BioGaia AB Third Quarter Earnings Conference Call for 2024 | 2024-10-22T08:00:00 |
| BioGaia AB Third Quarter Earnings Result for 2024 | 2024-10-22T00:00:00 |
| BioGaia AB Second Quarter Earnings Conference Call for 2024 | 2024-07-23T08:00:00 |
| BioGaia AB Second Quarter Earnings Result for 2024 | 2024-07-23T00:00:00 |
| BioGaia AB First Quarter Earnings Conference Call for 2024 | 2024-05-07T08:00:00 |
| BioGaia AB First Quarter Earnings Result for 2024 | 2024-05-07T00:00:00 |
| BioGaia AB Annual General Meeting for 2024 | 2024-05-07T00:00:00 |
Previous key dates
| Name | Key Date |
|---|---|
| BioGaia AB First Quarter Earnings Conference Call for 2024 | 2024-05-07T08:00:00 |
| BioGaia AB First Quarter Earnings Result for 2024 | 2024-05-07T00:00:00 |
| BioGaia AB Annual General Meeting for 2024 | 2024-05-07T00:00:00 |
| BioGaia AB Annual Report for 2023 | 2024-03-26T00:00:00 |
| BioGaia AB Fourth Quarter Earnings Conference Call for 2023 | 2024-02-07T09:30:00 |
| BioGaia AB Fourth Quarter Earnings Result for 2023 | 2024-02-07T00:00:00 |
| BioGaia AB Third Quarter Earnings Conference Call for 2023 | 2023-10-20T09:30:00 |
| BioGaia AB Third Quarter Earnings Results for 2023 | 2023-10-20T08:00:00 |
| BioGaia AB Second Quarter Earnings Conference Call for 2023 | 2023-07-21T09:30:00 |
| BioGaia AB Second Quarter Earnings Result for 2023 | 2023-07-21T00:00:00 |
| BioGaia AB Annual General Meeting for 2022 | 2023-05-05T16:00:00 |
| BioGaia AB First Quarter Earnings Conference Call for 2023 | 2023-05-05T09:30:00 |
| BioGaia AB First Quarter Earnings Result for 2023 | 2023-05-05T00:00:00 |
AJ Bell Management Limited (company number 03948391), AJ Bell Securities Limited (company number 02723420) and AJ Bell Asset Management Limited (company number 09742568) are authorised and regulated by the Financial Conduct Authority. All companies are registered in England and Wales at 4 Exchange Quay, Salford Quays, Manchester M5 3EE. See website for full details. AJ Bell procures the provision of the Morningstar Licensed Tools on an “as is” basis and does not guarantee the performance of or accept liability for the Licensed Tools. To the maximum extent permitted by law, AJ Bell excludes liability for the Licensed Tools, including liability for any failure, interruption, delay or defect in the performance of any Licensed Tool, unless it arises as a direct result of the negligence of AJ Bell.
© Copyright 2024 AJ Bell. All rights reserved.